Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
View on Grants.gov ↗ Sign in to save
- Type
- Grant
- Notice type
- G
- Agency
- National Institutes of Health
- Sub-agency
- HHS-NIH11
- Solicitation #
- PAR-25-175
- Posted
- Nov 6, 2024
- Response due
- Jan 7, 2028
- Archive date
- Feb 12, 2028
- CFDA / Assistance listing
- 93.393,93.394,93.395
- Award ceiling
- $500,000
- Total program funding
- $500,000
- Contact
- grantsinfo@nih.gov
- Source
- Grants.gov
Description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.